Condition: Tumours, Gynecological · Sponsor: GlaxoSmithKline
Advanced solid tumors are cancers that have spread to other parts of the body. While many treatments exist, most people become resistant to them, and the cancer returns. Researchers are developing new treatments that combine different medicines for those who do not respond to single medicine. This study is looking at how safe and tolerable Mocertatug Rezetecan (Mo-Rez) is, how the body handles it, and how well it works when used with other cancer medicines. The study will include participants with advanced solid tumors who have either not responded to standard treatments or cannot tolerate them or have no available effective treatment.
This description comes directly from the study's public registry record.
US GSK Clinical Trials Call Center · 877-379-3718 · GSKClinicalSupportHD@gsk.com
EU GSK Clinical Trials Call Center · +44 (0) 20 89904466 · GSKClinicalSupportHD@gsk.com
Always discuss trial participation with your own doctor first.
| GSK Investigational Site | La Jolla, California, United States | Recruiting |
| GSK Investigational Site | Aurora, Colorado, United States | Recruiting |
| GSK Investigational Site | Rochester, New York, United States | Recruiting |
| GSK Investigational Site | Durham, North Carolina, United States | Recruiting |
| GSK Investigational Site | Columbus, Ohio, United States | Recruiting |
| GSK Investigational Site | Buenos Aires, Argentina | Recruiting |
| GSK Investigational Site | Buenos Aires, Argentina | Recruiting |
| GSK Investigational Site | CABA, Argentina | Recruiting |
| GSK Investigational Site | Viedma, Argentina | Recruiting |
| GSK Investigational Site | Liverpool, New South Wales, Australia | Recruiting |
| GSK Investigational Site | Wollongong, New South Wales, Australia | Recruiting |
| GSK Investigational Site | Brussels, Belgium | Recruiting |
+ 69 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06796907